Lakewood-Amedex director reports initial holdings
Lakewood-Amedex Biotherapeutics Inc. director Leonard James DeRoma filed an initial Form 3 showing his existing stake in the company.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Lakewood-Amedex Biotherapeutics Inc. director Leonard James DeRoma filed an initial Form 3 showing his existing stake in the company. He reports direct ownership of 187,736 shares of common stock.
DeRoma also holds several series of warrants to acquire common stock at exercise prices ranging from $2.13 to $5.92 per share, with expiration dates between 2028 and 2032. The filing reflects current holdings rather than new purchases or sales.
Insider Trade Summary
Holdings reported, no transactions
Holdings
Insider
DeRoma Leonard James
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Warrants | -- | -- | -- |
| Holding | Warrants | -- | -- | -- |
| Holding | Warrants | -- | -- | -- |
| Holding | Warrants | -- | -- | -- |
| Holding | Warrants | -- | -- | -- |
| Holding | Warrants | -- | -- | -- |
| Holding | Common Stock; $0.0001 par value | -- | -- | -- |
Holdings:
Warrants — 113,177 contracts (Direct);
Common Stock; $0.0001 par value — 187,736 shares (Direct)
Key Figures
Common stock holdings: 187,736 shares
Warrant exercise price: $2.13 per share
Underlying shares at $2.13: 8,446 shares
+5 more
8 metrics
Common stock holdings
187,736 shares
Direct ownership reported on Form 3
Warrant exercise price
$2.13 per share
Warrants on common stock expiring July 11 2032
Underlying shares at $2.13
8,446 shares
Underlying common stock for $2.13 warrants
Warrant exercise price
$2.78 per share
Warrants on common stock expiring July 11 2031
Underlying shares at $2.78
8,446 shares
Underlying common stock for $2.78 warrants
Warrant exercise price
$2.37 per share
Warrants on common stock expiring July 11 2030
Underlying shares at $2.37
8,446 shares
Underlying common stock for $2.37 warrants
Largest warrant block at $5.92
40,541 shares
Underlying common stock for $5.92 warrants expiring Feb 29 2028
Key Terms
Form 3, warrants, exercise price, expiration date, +1 more
5 terms
Form 3 regulatory
"DeRoma filed an initial Form 3 showing his existing stake in the company."
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
warrants financial
"DeRoma also holds several series of warrants to acquire common stock."
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
exercise price financial
"Warrants have exercise prices ranging from $2.13 to $5.92 per share."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"Warrant expiration dates range between 2028 and 2032."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"Each warrant series lists common stock as the underlying security."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the LABT Form 3 filing by Leonard James DeRoma show?
The Form 3 shows Leonard James DeRoma’s existing ownership in LABT, including 187,736 common shares and multiple warrant positions. It is an initial ownership report, not a record of new stock purchases or sales.
What warrants are disclosed in Leonard James DeRoma’s LABT Form 3?
The filing lists several warrant series on LABT common stock, with exercise prices from $2.13 to $5.92 per share and expirations between 2028 and 2032. Each series covers a specific number of underlying common shares.
Why is a Form 3 important for Lakewood-Amedex (LABT) investors?
Form 3 establishes an insider’s starting ownership position in LABT when they become subject to reporting rules. It helps investors track future Form 4 and Form 5 filings against this baseline to understand changes in insider holdings over time.
AI-generated analysis. How Rhea-AI works. Not financial advice.
